Last reviewed · How we verify

Pyridoxine plus prednisolone — Competitive Intelligence Brief

Pyridoxine plus prednisolone (Pyridoxine plus prednisolone) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Combination therapy (vitamin B6 + corticosteroid). Area: Immunology / Rheumatology / Neurology.

phase 3 Combination therapy (vitamin B6 + corticosteroid) Immunology / Rheumatology / Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Pyridoxine plus prednisolone (Pyridoxine plus prednisolone) — Lady Hardinge Medical College. Pyridoxine (vitamin B6) supports immune function and nervous system health while prednisolone suppresses inflammatory and immune responses through glucocorticoid receptor activation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Pyridoxine plus prednisolone TARGET Pyridoxine plus prednisolone Lady Hardinge Medical College phase 3 Combination therapy (vitamin B6 + corticosteroid)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Combination therapy (vitamin B6 + corticosteroid) class)

  1. Lady Hardinge Medical College · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Pyridoxine plus prednisolone — Competitive Intelligence Brief. https://druglandscape.com/ci/pyridoxine-plus-prednisolone. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: